Patients enrolled in select federal health insurance programs could have up to $500 of hemp-derived products covered each year beginning as early as April 1, according to new details about the cannabis initiative that’s being implemented by the Centers for Medicare & Medicaid Services (CMS).
The CBD-focused plan will also allow a certain amount of THC in products, but the agency said the planned rules are subject to change if federal hemp policy changes, as is currently expected under a law set to take effect later this year.
President Donald Trump signed an executive order in December that calls on the attorney general to finalize a rule federally rescheduling marijuana that also contained components to “improve access” to full-spectrum CBD products. To that end, the CMS update posted on Friday details how certain of its “Innovation Center” models will facilitate a pilot program providing coverage to regulated, hemp-derived cannabidiol.
Participants would be required to ensure that CBD is sourced from “a legally compliant source and high-quality farm,” prepared as an oral solution and tested for cannabinoid content so that available products contain no more than 0.3 percent delta-9 THC by dry weight and up to 3 milligrams of total THC
Read full article on Marijuana Moment
